New Treatment Update
David Choi, MD
Management of Fulminant Ulcerative Colitis
Parambir S. Dulai, MD
Therapeutic Drug Monitoring and Treat to Target
Byron Vaughn, MD, MS
The Evolution of Treating Ulcerative Colitis
Edward V. Loftus, JR., M.D.
Checkpoint Inhibitor Colitis
Michael Kattah, MD, PhD
Post-Operative Crohns Disease
Maneesh Dave, M.D., M.P.H.
Emerging Therapies in Inflammatory Bowel Disease
Peter D. Higgins, MD, PhD
Microbiome in IBD
Ronald Hsu, M.D., FACG, FACP
Updates in IBD Dysplasia Screening
Jesse Lee Stondell, M.D.
Through the Looking Glass: Managing IBD Care for Diverse Patient Populations
Lisa B. Malter, MD
A Multi-Disciplinary Panel Discussion
Freddy Caldera, DO
Shubha Bhat, PharmD, MS, BCACP
Stacy A Ogbeide, PSYD, ABPP, CSOWM
Treat-To-Target and Therapy De-Escalation
Christina Ha, MD, FACG, AGAF
Positioning Therapies in Inflammatory Bowel Disease
Eric J. Mao, M.D.
Basics of Medical Management of IBD
Fellow Foundations Lecture 2: Incorporating Biosimilars into Clinical Practice
Fellow Foundations Lecture 3: Management of Ulcerative Colitis in Adults
Loading...
We're glad to see you're enjoying Crohn's Colitis Professional… but how about a more personalized experience?
Press cancel to remain on Crohn's Colitis Professional. Press the link below or the continue button to keep going.